The Distribution Partnering Terms and Agreements
report provides comprehensive understanding and unprecedented access to the
distribution partnering agreements entered into by the worlds leading biopharma
companies.
The report provides a detailed understand and
analysis of how and why companies enter distribution deals.
The majority of deals are multicomponent whereby the
licensor offers a right to distribute the resultant product of the research
collaboration. There are also numerous pure distribution deals whereby the
products originator takes on a distribution partner in order to maximize a
products presence in the marketplace.
Understanding the flexibility of a prospective
partner’s negotiated deals terms provides critical insight into the negotiation
process in terms of what you can expect to achieve during the negotiation of
terms. Whilst many smaller companies will be seeking details of the payments
clauses, the devil is in the detail in terms of how payments are triggered –
contract documents provide this insight where press releases and databases do
not.
This report contains a comprehensive listing of all
distribution deals announced since 2009 as recorded in the Current Agreements
deals and alliances database, including financial terms where available, plus
links to online copies of actual distribution contract documents as submitted
to the Securities Exchange Commission by companies and their partners.
Contract documents provide the answers to numerous
questions about a prospective partner’s flexibility on a wide range of
important issues, many of which will have a significant impact on each party’s
ability to derive value from the deal.
Complete
Report Copy @ http://www.rnrmarketresearch.com/distribution-partnering-terms-and-agreements-market-report.html
The initial chapters of this report provide an
orientation of distribution dealmaking and business activities. Chapter 1
provides an introduction to the report, whilst chapter 2 provides an analysis
of the trends in distribution as well as a discussion on the merits of the type
of deal.
Each listing is organized as an appendix by company
A-Z, stage of development at signing, therapeutic area and industry type. Each
deal title links via hyperlink to an online version of the deal record
including, where available, the actual contract document.
The report also includes numerous table and figures
that illustrate the trends and activities in distribution dealmaking since
2009.
In conclusion, this report provides everything a
prospective dealmaker needs to know about distribution alliances.
Key
benefits
Distribution Partnering Terms and Agreements report
provides the reader with the following key benefits:
- In-depth understanding of distribution deal trends
since 2009
- Analysis of the structure of distribution
agreements with numerous real life case studies
- Comprehensive access to over 1,900 actual
distribution deals entered into by the world’s biopharma companies
- Detailed access to actual distribution contracts
enter into by the leading fifty bigpharma companies
- Insight into the terms included in a distribution
agreement, together with real world clause examples
- Understand the key deal terms companies have
agreed in previous deals
- Undertake due diligence to assess suitability of
your proposed deal terms for partner companies
Request
a Sample Copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=99761
Report
scope
Distribution Partnering Terms and Agreements is
intended to provide the reader with an in-depth understanding of the
distribution trends and structure of deals entered into by leading biopharma
companies worldwide.
Distribution
Partnering Terms and Agreements includes:
- Trends in distribution dealmaking in the biopharma
industry since 2009
- Analysis of distribution deal structure
- Case studies of real-life distribution deals
- Access to over 1,900 distribution deals documents
- The leading distribution deals by value since 2009
- Most active distribution dealmakers since 2009
- The leading distribution partnering resources
In Distribution Partnering Terms and Agreements, the
available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Therapeutic area
- Technology type
Each deal title links via Weblink to an online
version of the actual deal record, providing easy access to each contract
document where available.
The Distribution Partnering Terms and Agreements
report provides comprehensive access to available records for over 1,900
distribution deals, including contract documents where available. Analyzing
actual contract agreements allows assessment of the following:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the
partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How aresalesand payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and
manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions
have been agreed?
- Which boilerplate clauses does the company insist
upon?
- Which boilerplate clauses appear to differ from
partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon
for agreement law?
Buy
a Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99761
No comments:
Post a Comment
Note: only a member of this blog may post a comment.